Quarterly report pursuant to Section 13 or 15(d)

1. Organization and Business (Details Narrative)

v3.20.2
1. Organization and Business (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Jun. 23, 2020
May 08, 2020
May 07, 2020
Jul. 28, 2020
Jul. 21, 2020
Jun. 23, 2020
Jun. 11, 2020
May 28, 2020
May 18, 2020
Apr. 30, 2020
Mar. 22, 2020
Jan. 22, 2020
Mar. 11, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 18, 2019
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Net loss                           $ (2,007,209) $ (2,555,233) $ (391,101,155) $ (9,277,867)              
Net Cash Used in Operating Activities                               (5,316,579) (4,636,416)              
Accumulated deficit                           (458,988,674)   (458,988,674)         $ (66,047,135)      
Stockholders equity                           63,136,830 8,735,356 63,136,830 8,735,356   $ 63,218,056 $ 4,387,868 9,086,702 $ 9,190,612 $ 10,767,514 $ 12,839,771
Current assets                           54,864,958   54,864,958         4,646,249      
Cash, Cash Equivalents, and Restricted Cash                           50,461,566 $ 633,561 50,461,566 633,561       305,121     $ 3,085,026
Current liabilities                           6,990,911   6,990,911         8,296,385      
Working capital                           $ 47,874,047   47,874,047         $ (3,650,136)      
Warrant exercise price       $ 3.30     $ 0.21                                  
Proceeds from issuance of equity                               $ 44,755,671 $ 1,757,552              
Proceeds from exercise of warrants       $ 50,511     $ 5,649,319                                  
Warrants exercised       16,670     29,666,283                                  
Investor [Member]                                                
Proceeds from investors           $ 3,600,000                                    
Common Stock [Member]                                                
Stock converted, shares converted 65,476,190                                              
Warrants [Member]                                                
Proceeds from exercise of warrants         $ 55,011                                      
Warrants exercised         16,670                                      
January 2020 Offering [Member] | Warrants [Member]                                                
Warrants issued                       500,000                        
Warrant exercise price                       $ 3.90                        
Securities Purchase Agreement [Member]                                                
Warrants issued                         65,476,190                      
Warrant exercise price                         $ 0.26                      
Debt face amount                         $ 13,750,000                      
Funding amount                         $ 11,000,000                      
Debt converted, shares issued 65,476,190                                              
PPP [Member]                                                
Proceeds from loans                   $ 366,267                            
Interest rate                   1.00%                            
Warrant Exercise Agreement [Member] | Private Transaction [Member]                                                
Warrant exercise price                       $ 0.34                        
Proceeds from exercise of warrants                       $ 170,000           $ 718,879            
Securities Purchase Agreement [Member] | Warrants [Member]                                                
Stock issued new, shares   12,000,000 8,000,000         20,000,000 7,500,000   4,000,000                          
Proceeds from issuance of equity   $ 5,448,000 $ 2,800,000         $ 30,000,000 $ 9,000,000   $ 1,000,000                          
Sale price, per share   $ 0.454 $ 0.35         $ 1.50 $ 1.20   $ 0.2568